Replay available

Trevi Therapeutics, Inc. (TRVI) Q4 2025 Earnings Call

Trevi Therapeutics, Inc. (NASDAQ: TRVI) Q4 2025 earnings conference call, held 2026-03-17. Replay captured from the company's public earnings webcast.

Tue, March 17, 2026 at 4:30 PMendedReplay
Trevi Therapeutics, Inc. (TRVI) Q4 2025 Earnings Call

Hosted by

Featured presenters

Jennifer Good

President and CEO

David Hastings

Chief Financial Officer

Dr. James Casella

Chief Development Officer

Farrell Simon

Chief Commercial Officer

Rana Ruiz

Analyst, Lyric Partners

Judah Frommer

Analyst, Morgan Stanley

Alexa Deamer

Analyst, CantorBridge-Gerald

Brandon Folks

Analyst, HC Rainwright

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Trevi Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.878 Good afternoon and welcome to the Trevi Therapeutics fourth quarter and year-end 2025 00:00:04.878 -- 00:00:10.025 earnings conference call. At this time, all participants are in a listen-only mode. 00:00:10.025 -- 00:00:13.931 After today's presentation, there will be an opportunity to ask questions. 00:00:13.931 -- 00:00:18.537 To ask a question during the session, you will need to press star 1-1 on your telephone. 00:00:18.537 -- 00:00:21.782 You will then hear an automated message advising your hand is raised. 00:00:21.782 -- 00:00:24.906 To withdraw your question, please press star 1-1 again. 00:00:24.906 -- 00:00:28.600 Please be advised that today's conference is being recorded. 00:00:28.600 -- 00:00:32.646 Various remarks that management makes during this conference call about the company's 00:00:32.646 -- 00:00:37.653 future expectations, plans, and prospects constitute forward-looking statements for 00:00:37.653 -- 00:00:42.239 purposes of the safe harbor provisions under the Private Securities Litigation Reform 00:00:42.239 -- 00:00:47.346 Act of 1995. Actual results may differ materially from those indicated 00:00:47.346 -- 00:00:51.872 by these forward-looking statements as a result of various important factors, including 00:00:51.872 -- 00:00:57.100 those discussed in the risk factors section of the company's most recent annual report 00:00:57.100 -- 00:01:01.574 on Form 10-K, which the company filed with the SEC this afternoon. 00:01:01.574 -- 00:01:06.579 In addition, any forward-looking statements represent the company's views only as 00:01:06.579 -- 00:01:11.223 of today and should not be relied upon as representing the company's views as of any 00:01:11.223 -- 00:01:16.609 subsequent date. While the company may e...